Recipharm AB:企業の戦略的SWOT分析

◆英語タイトル:Recipharm AB - Strategic SWOT Analysis Review
◆商品コード:GDPH133157SA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:45
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥28,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥42,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Recipharm AB – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

Recipharm AB (Recipharm) is a contract development and manufacturing organization (CDMO) that offers manufacturing, and development and technology services. The company’s manufacturing services include contract manufacturing of pharmaceuticals such as semi-solids, and oral liquids, solid dose, sterile products, besides clinical trial materials including APIs and other drugs. Recipharm’s development and technology services supports customers from initial product concept to the approved commercial pharmaceutical drug. It includes services such as raw material supply, formulation, validated analytical methods, among others. The company operates in the UK, Germany, Spain, Italy, Sweden, France, Portugal, India, Israel and the US. Recipharm is headquartered in Stockholm, Sweden.

Recipharm AB Key Recent Developments

Mar 02,2021: Recipharm names 2020 International Environmental Award winner
Feb 10,2021: Recipharm bolsters biologics offering
Jan 28,2021: Recipharm publishes report for the fourth quarter and full year 2020
Dec 09,2020: Recipharm invests USD 2.5 million in clinical GMP capacity for active pharmaceutical ingredients
Nov 10,2020: Recipharm invests in its pMDI valves production capacity

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Recipharm AB – Key Facts
Recipharm AB – Key Employees
Recipharm AB – Key Employee Biographies
Recipharm AB – Major Products and Services
Recipharm AB – History
Recipharm AB – Company Statement
Recipharm AB – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Recipharm AB – Business Description
Business Segment: ADS
Overview
Performance
Business Segment: D&L
Overview
Performance
Business Segment: MFG-S
Overview
Performance
Business Segment: MFG-SO
Overview
Performance
Geographical Segment: France
Performance
Geographical Segment: Germany
Performance
Geographical Segment: India
Performance
Geographical Segment: Italy
Performance
Geographical Segment: Other
Performance
Geographical Segment: Portugal
Performance
Geographical Segment: Spain
Performance
Geographical Segment: Sweden
Performance
Geographical Segment: UK
Performance
Recipharm AB – Corporate Strategy
Recipharm AB – SWOT Analysis
SWOT Analysis – Overview
Recipharm AB – Strengths
Recipharm AB – Weaknesses
Recipharm AB – Opportunities
Recipharm AB – Threats
Recipharm AB – Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
Recipharm AB, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Recipharm AB, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Recipharm AB, Recent Deals Summary
Section 4 – Company’s Recent Developments
Mar 02, 2021: Recipharm names 2020 International Environmental Award winner
Feb 10, 2021: Recipharm bolsters biologics offering
Jan 28, 2021: Recipharm publishes report for the fourth quarter and full year 2020
Dec 09, 2020: Recipharm invests USD 2.5 million in clinical GMP capacity for active pharmaceutical ingredients
Nov 10, 2020: Recipharm invests in its pMDI valves production capacity
Nov 05, 2020: Recipharm publishes its interim report for the third quarter 2020
Oct 13, 2020: Recipharm invests EUR 2.6 million in Kaysersberg facility
Jul 27, 2020: Recipharm publishes its interim report for the second quarter 2020
Jul 13, 2020: Recipharm doubles EBIT and expects second quarter results to be stronger than analyst consensus
May 07, 2020: Recipharm publishes its interim report January-March 2020
Section 5 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Recipharm AB, Key Facts
Recipharm AB, Key Employees
Recipharm AB, Key Employee Biographies
Recipharm AB, Major Products and Services
Recipharm AB, History
Recipharm AB, Other Locations
Recipharm AB, Subsidiaries
Recipharm AB, Key Competitors
Recipharm AB, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Recipharm AB, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Recipharm AB, Recent Deals Summary

★海外企業調査レポート[Recipharm AB:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Target Corp:企業の戦略・SWOT・財務情報
    Target Corp - Strategy, SWOT and Corporate Finance Report Summary Target Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • ADT LLC:戦略・SWOT・企業財務分析
    ADT LLC - Strategy, SWOT and Corporate Finance Report Summary ADT LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • JCR Pharmaceuticals Co Ltd (4552):企業の財務・戦略的SWOT分析
    JCR Pharmaceuticals Co Ltd (4552) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Siem Offshore Inc (SIOFF):企業の財務・戦略的SWOT分析
    Summary Siem Offshore Inc (Siem Offshore), a subsidiary of Siem Industries Inc is a marine service provider that owns and operates modern offshore support vessels for the offshore oil and gas industries. It offers shipbuilding, ordering and delivery of new vessels, acquisition of modern second-hand …
  • ICICI Bank Ltd:戦略・SWOT・企業財務分析
    ICICI Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary ICICI Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Invenergy LLC:発電所・企業SWOT分析
    Invenergy LLC - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (exec …
  • Canada Energy Partners Inc (CE):石油・ガス:M&Aディール及び事業提携情報
    Summary Canada Energy Partners Inc (Canada Energy) is a natural gas exploration and development company. The company concentrates on mid-stream supplying of water disposal services, development of a wellbore mining technology and energy or mineral exploring. It develops a wellbore mining technology …
  • Alnylam Pharmaceuticals Inc (ALNY):製薬・医療:M&Aディール及び事業提携情報
    Summary Alnylam Pharmaceuticals Inc (Alnylam) is a biopharmaceutical company which discovers, develops and commercializes therapeutics based on Ribo Nucleic Acid interference (RNAi). The company offers a broad pipeline of investigational RNAi therapeutics in the areas of genetic medicines, hepatic i …
  • Gujarat State Petroleum Corp Ltd:企業の戦略的SWOT分析
    Gujarat State Petroleum Corp Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • BlueWillow Biologics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary BlueWillow Biologics Inc (BlueWillow), formerly NanoBio Corp is a biopharmaceutical company that develops intranasal and intramuscular vaccines for the prevention and treatment of infectious diseases. The company’s pipeline products include anthrax, H5 influenza, pertussis, RSV, HSV-2, and s …
  • Insys Therapeutics Inc (INSY):製薬・医療:M&Aディール及び事業提携情報
    Summary Insys Therapeutics Inc (Insys) is a specialty pharmaceutical company, which discovers, develops and commercializes novel drug delivery systems of therapeutic compounds. The company harnesses its proprietary sublingual spray technology to develop pharmaceutical cannabinoids. Its flagship prod …
  • ITV plc (ITV):企業の財務・戦略的SWOT分析
    ITV plc (ITV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • The Prudential Insurance Company of America:企業のM&A・事業提携・投資動向
    The Prudential Insurance Company of America - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The Prudential Insurance Company of America Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, det …
  • Invicta Holdings Limited:企業の戦略・SWOT・財務分析
    Invicta Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Invicta Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Qurain Petrochemical Industries Co (ALQURAIN):石油・ガス:M&Aディール及び事業提携情報
    Summary Qurain Petrochemical Industries Co (QPIC), a subsidiary of Kuwait Projects Company Holding KSC is an investment holding company that invests in petrochemical industry and related sectors. The company develops business and financial solutions. It provides investment portfolio such as EQUATE, …
  • Qdoba Restaurant Corporation:企業の戦略・SWOT・財務情報
    Qdoba Restaurant Corporation - Strategy, SWOT and Corporate Finance Report Summary Qdoba Restaurant Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Deutsche Bank AG (DBK):企業の財務・戦略的SWOT分析
    Deutsche Bank AG (DBK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Jindal Steel & Power Ltd:企業の戦略・SWOT・財務情報
    Jindal Steel & Power Ltd - Strategy, SWOT and Corporate Finance Report Summary Jindal Steel & Power Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • National HealthCare Corp (NHC):企業の財務・戦略的SWOT分析
    Summary National HealthCare Corp (NHC) is a health care service provider that offers home-care and assisted living services. The center offers rehabilitative care, skilled nursing care, Alzheimer's and memory care, residential and assisted living, home care, hospice care and long term care insurance …
  • Patanjali Ayurved Ltd:企業の戦略的SWOT分析
    Patanjali Ayurved Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆